537 results on '"Biomedical and dental materials"'
Search Results
152. Researchers Submit Patent Application, "Tissue Former For Dental Implants", for Approval (USPTO 20230240814).
- Published
- 2023
153. Patent Application Titled "Lymph Conduction System Implant and Method of Using Same" Published Online (USPTO 20230240830).
- Abstract
"The invention, in another form, is directed to a lymph conduction system implant that includes a stent graft, a drug eluting porous membrane, and a drug. A drug eluting porous membrane is connected to the inferior lymphangion region end of the non-porous tubular side wall of the stent graft. The lymph conduction system implant according to claim 1, wherein the porous membrane is a drug eluting porous membrane that carries a drug. [Extracted from the article]
- Published
- 2023
154. Researchers Submit Patent Application, "Electrically Anesthetizing A Peripheral Nerve With On-Demand Electrical Nerve Block For Chronic Pain Management", for Approval (USPTO 20230233848).
- Abstract
The method of claim 17, further comprising recharging the blocking electrode contact and/or the return electrode contact, wherein the blocking electrode contact and the return electrode contact are each at least partially enclosed in sub-capsules within the capsule that are connected by a channel for recharging. OD-ENB is a patient-specific intervention that can be adjusted over time to provide sustained relief for a long period of time and is customizable for the individual patient, giving patients control of their pain management without opioids. These treatment modalities are ill suited to address the needs of patients in terms of adequate pain relief, quality of life, and convenience, making patients feel as if their pain management is out of their control.". [Extracted from the article]
- Published
- 2023
155. Patent Issued for Patient-specific fixation plate with spacing elements (USPTO 11701150).
- Abstract
In a closed wedge osteotomy, a wedge of bone having a specified angle is removed from the tibia bone below the knee, and the tibia bone is closed along the wedge. The fixation plate kit according to claim 1, wherein the fixation plate is configured to be secured in a predetermined position on the bone, further wherein the bone interface side of the spacing elements has contours following surface contours of the bone at the predetermined position. The spacing element has a body with a bone interface side and a plate interface side and sidewalls extending thereinbetween, said bone interface side having a bone contacting surface having contours conforming to surface contours of the bone. [Extracted from the article]
- Published
- 2023
156. Patent Application Titled "Devices Comprising Hyaluronic Acid And Silk Fibroin" Published Online (USPTO 20230201414).
- Subjects
PATENT applications ,HYALURONIC acid ,SILK fibroin ,PATENT offices ,INTERNET publishing - Abstract
The method of claim 38, wherein adding the active agent to the combined microneedle-base layer mold comprises applying the active agent to at least a portion of the combined microneedle-base layer mold inner surface. The method of claim 49, wherein adding the active agent to the microneedle layer mold comprises applying the active agent to a least a portion of the microneedle layer mold inner surface. A method of fabricating the device of any of claims 10-22, the method comprising: preparing a solution comprising hyaluronic acid or a combination of silk fibroin and hyaluronic acid; filling a combined microneedle-base layer mold with the solution; removing a solidified microneedle-base layer from the combined microneedle-base layer mold; and crosslinking the solidified microneedle-base layer. In some embodiments, the methods comprise at least one or all of: preparing a solution comprising hyaluronic acid or a combination of silk fibroin and hyaluronic acid; filling a combined microneedle-base layer mold with the solution; removing a solidified microneedle-base layer from the combined microneedle-base layer mold; crosslinking the solidified microneedle-base layer; and adding an active agent. [Extracted from the article]
- Published
- 2023
157. Patent Issued for Blood pump assembly and method of use thereof (USPTO 11684768).
- Subjects
PATENT offices ,PATENTS ,MEDICAL equipment reliability - Abstract
A method of treating heart failure in a subject comprising implanting the blood pump assembly of the iVAS of claim 32 into a blood vessel of a subject and cycling the blood pump through a series of inflation/deflation cycles. A method of treating heart failure in a subject comprising implanting the blood pump assembly of claim 1 into a blood vessel of a subject and cycling the blood pump through a series of inflation/deflation cycles. The method includes implanting the blood pump assembly of the disclosure into a blood vessel of a subject and cycling the blood pump through a series of inflation/deflation cycles." A method of providing ventricular assistance to a subject via counterpulsation comprising implanting the blood pump assembly of claim 1 into a blood vessel of a subject and cycling the blood pump through a series of inflation/deflation cycles. [Extracted from the article]
- Published
- 2023
158. Patent Issued for Bioactive components conjugated to substrates of microneedle arrays (USPTO 11672964).
- Abstract
"Accordingly, although transdermal delivery of biologics using microneedle-array based devices offers attractive theoretical advantages over prevailing oral and needle-based drug delivery methods, considerable practical limitations exist with conventional delivery systems and methods." The one or more bioactive components can be locally concentrated in the plurality of microneedles so that the one or more bioactive components are generally present only in an upper half of respective microneedles in the microneedle array. The method of claim 7, wherein the removal of portions from the sheet array comprises forming the microneedle array so that the one or more bioactive component is concentrated in the respective microneedles of the microneedle array and the one or more bioactive components are substantially absent from the base portion. [Extracted from the article]
- Published
- 2023
159. "Specimen Retrieval Device" in Patent Application Approval Process (USPTO 20230181174).
- Abstract
Keywords: 3-Hydroxybutyric Acid; Acyclic Hydrocarbons; Alcohols; Alkalies; Alkenes; Amides; Anions; Biocompatible Materials; Bioengineering; Biomedical and Dental Materials; Biomedicine; Biotechnology; Carbonates; Carbonic Acid; Carboxylic Acids; Epoxy Compounds; Esters; Ethylene Glycols; Ethylene Oxide; Ethylenes; Health and Medicine; Hydroxybutyrates; Lactones; Organic Chemicals; Patent Application; Surgery EN 3-Hydroxybutyric Acid Acyclic Hydrocarbons Alcohols Alkalies Alkenes Amides Anions Biocompatible Materials Bioengineering Biomedical and Dental Materials Biomedicine Biotechnology Carbonates Carbonic Acid Carboxylic Acids Epoxy Compounds Esters Ethylene Glycols Ethylene Oxide Ethylenes Health and Medicine Hydroxybutyrates Lactones Organic Chemicals Patent Application Surgery 1305 1305 1 07/03/23 20230707 NES 230707 2023 JUL 9 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- A patent application by the inventors Banerjee, Saumya (Southington, CT, US); Baril, Jacob C. (Norwalk, CT, US); Dinino, Matthew A. (Newington, CT, US); Ebersole, Garrett P. (Hamden, CT, US); Pilletere, Roy J. (Middletown, CT, US); Roy, Nicolette L. (Windsor Locks, CT, US); Thomas, Justin J. (New Haven, CT, US), filed on November 10, 2022, was made available online on June 15, 2023, according to news reporting originating from Washington, D.C., by NewsRx correspondents. The specimen retrieval device of claim 1, wherein the centering ring is formed of a biocompatible material selected from polymeric materials derived from lactones, carbonates, dioxanones, ethylene glycol, ethylene oxide, ester amides, g-hydroxyvalerate, b-hydroxypropionate, alpha-hydroxy acid, hydroxybutyrates, poly (ortho esters), hydroxy alkanoates, polyurethanes, polyanhydrides, polybutesters, copolymers thereof, or combinations thereof "7. [Extracted from the article]
- Published
- 2023
160. Patent Issued for Bone graft delivery devices, systems and kits (USPTO 11666455).
- Abstract
"Autogenous bone (bone from the patient) or allograft bone (bone from another individual) are the most commonly used materials to induce bone formation. A bone graft delivery kit comprising: at least one hollow tube constructed to receive bone graft and having a proximal end and a distal end; a funnel configured (i) to be disposed at the proximal end of the at least one hollow tube, (ii) to receive bone graft material and (iii) to deliver bone graft material into the at least one hollow tube; and at least one plunger adapted for inserting into the proximal end of the at least one hollow tube; an implant that is configured to engage the distal end of the hollow tube, the implant comprising an expansion screw. Similarly, allograft bone and other bone graft substitutes, although eliminating the need for a second surgery, have drawbacks in that they have yet to be proven as cost effective and efficacious substitutes for autogenous bone fusion. Also, in some surgical procedures, the devices for inserting bone graft material are applied within a cannula inserted or placed in the surgical area, further limiting the size and/or profile of the bone graft insertion device. [Extracted from the article]
- Published
- 2023
161. Researchers Submit Patent Application, "Multi-Layer Nanofiber Scaffolds", for Approval (USPTO 20230174928).
- Published
- 2023
162. Patent Issued for Bone graft delivery system and method for using same (USPTO 11660208).
- Published
- 2023
163. Patent Application Titled "Pressure Sensor Arrangement And Method" Published Online (USPTO 20230158288).
- Published
- 2023
164. Patent Issued for Ophthalmological implant (USPTO 11648105).
- Abstract
An ophthalmological implant as claimed in claim 1, wherein the color pigment is harder than the material of the main structure. An ophthalmological implant as claimed in claim 1, wherein the main structure is formed by a main structure material and the enclosures are formed by an enclosure material, wherein the main structure material and the enclosure material differ from one another. This ensures that the at least one color pigment of the pigment arrangement is in particular sealed off, in other words encapsulated, which improves the biocompatibility of the ophthalmological implant, in particular even after adapting the latter. [Extracted from the article]
- Published
- 2023
165. Patent Issued for Systems and methods for incontinence control (USPTO 11648100).
- Published
- 2023
166. Patent Issued for Bioartificial pancreas (USPTO 11642212).
- Subjects
PATENT offices ,PANCREAS ,HYPERGLYCEMIA ,PEPTIDE hormones ,BIOMEDICAL materials - Abstract
Artificial Organs, Artificial Pancreas, Bioartificial Pancreas, Biocompatible Materials, Bioengineering, Biomedical Engineering, Biomedical and Dental Materials, Biomedicine, Biotechnology, Business, Endocrinology, Gastroenterology, Glucagon, Health and Medicine, Hormones, ISLA Technologies Inc., Insulin Dependent Diabetes Mellitus, Metabolic Disorders, Nutritional and Metabolic Diseases and Conditions, Pancreas, Pancreas Research, Peptide Hormones, Peptide Proteins, Proinsulin, Type 1 Diabetes Patent URL (for desktop use only): https://ppubs.uspto.gov/pubwebapp/external.html?q=(11642212)&db=USPAT&type=ids Keywords for this news article include: Biotechnology, Biomedical Engineering, Biomedical and Dental Materials, Biomedicine, Business, Glucagon, Proinsulin, Endocrinology, Bioengineering, Type 1 Diabetes, Gastroenterology, Peptide Hormones, Peptide Proteins, Artificial Organs, Pancreas Research, Health and Medicine, Metabolic Disorders, Bioartificial Pancreas. [Extracted from the article]
- Published
- 2023
167. ارزیابی بیرونی گروه آموزشی ترمیمی و مواد دندانی دانشکده دندانپزشکی دانشگاه علوم پزشکی بابل
- Author
-
مصلح امیردهی, هادی, نیستانی, محمدرضا, and جهانیان, ایمان
- Abstract
Aims: Today, improving the quality of higher education system is of basic consideration for the managers. In the meantime, using the external evaluation strategy plays a key role to achieve the qualitative university systems. The aim of this study was to external evaluation of Department of Operative Dentistry and Dental School of Babol University of Medical Sciences. Instrument & Methods: In this descriptive study in 2014-15 academic year, 109 members of the Department of Operative Dentistry and Dental School of Babol University of Medical Sciences (students, faculty members, group manager and group staffs) were participated in the external evaluation process the students were selected by categorized sampling method and others by census method. Questionnaire, interview, checklist and observation were used to collect data. In order to analyze the data SPSS 21 software and weighting method (valuation) were used. Findings: In viewpoint of the evaluated group, “faculty members” and “equipment and constructions” factors were in nearly desirable condition and “group manager” and “goals and mission” factors were in desirable condition. Conclusion: Department of Operative Dentistry and Dental School, Babol University of Medical Sciences, is in desirable condition in terms of external evaluation. [ABSTRACT FROM AUTHOR]
- Published
- 2015
168. Os 100 artigos mais citados nos primeiros 100 anos do hidróxido de cálcio como um material dentário (1920-2020): uma análise bibliométrica
- Author
-
Marcela Batista Pereira de Carvalho, Pablo Silveira dos Santos, Jacy Ribeiro de Carvalho-Junior, Manoel Damião de Sousa-Neto, Paulo Antônio Martins-Júnior, Mariane Cardoso, Carla Massignan, and Fernanda Cristina Pimentel Garcia
- Subjects
Biomedical and dental materials ,Calcium hydroxide ,Hidróxido de calcio ,Materiales biomédicos y dentales ,Base de datos ,Scholarly communication ,Comunicación académica ,Databases ,Bibliometria ,Hidróxido de cálcio ,Bibliometrics ,Bibliometría ,General Earth and Planetary Sciences ,Materiais biomédicos e odontológicos ,Comunicação acadêmica ,Bases de dados ,General Environmental Science - Abstract
Celebrating the centenary of calcium hydroxide (CH), the aim of this study was to analyze the 100 most-cited papers on this biomaterial. The bibliometric analysis was conducted in the Web of Science Core Collection (WoS-CC) database. Title, authorship information, study design, year, journal, number of citations, CH use, and fields of Dentistry were extracted. The number of citations in the WoS-CC, Scopus, and Google Scholar databases was cross-matched with the Spearman correlation. From the 1,596 papers identified, a list was compiled with the 100 most-cited papers. The number of citations in WoS-CC ranged from 78 to 384 (mean: 131.4). The main CH uses were: intracanal dressing (61%), and pulp protection (29%). The fields of Dentistry with most studies on CH were Endodontics (62%) and Operative Dentistry (30%). The most frequent study design was laboratory studies (44%). Three hundred and thirty-five authors from 29 countries were identified. The United States of America (USA) was the leading country with 23 articles. Dag Ørstavik was the author with the most papers and citations (9 papers; 1,118 citations). Most papers were published between 1991 and 2015 and in the Journal of Endodontics (38%). A very strong positive correlation was observed among the number of citations in the databases. The 100 most-cited papers were published mainly by European journals or from USA, with laboratory and multifaceted interventional designs. The present study celebrated the centenary of CH, highlighting the role and importance of this biomaterial in Dentistry. Celebrando el centenario del hidróxido de calcio (HC), el objetivo de este estudio fue analizar los 100 artículos más citados sobre este biomaterial. Análisis bibliométrico se realizó en la base de datos Web of Science Core Collection (WoS-CC). Se extrajo título, información de autoría, diseño del estudio, año, revista, número de citas, uso de HC y áreas de la Odontología. Se cruzó número de citas en las bases de datos WoS-CC, Scopus y Google Scholar con la correlación de Spearman. De los 1.596 artículos identificados, se compiló una lista de los 100 artículos más citados. El número de citas en WoS-CC osciló entre 78 y 384 (media: 131,4). Los principales usos del HC fueron: medicación intracanal (61%) y protección pulpar (29%). Las áreas de la Odontología con más estudios sobre HC fueron Endodoncia (62%) y Odontología Restaurativa (30%). El diseño de estudio más frecuente fue el de laboratorio (44%). Se identificaron 335 autores de 29 países. Estados Unidos fue el país líder con 23 artículos. Dag Ørstavik fue el autor con más artículos y citas (9 artículos; 1118 citas). La mayoría de los artículos se publicaron entre 1991 y 2015 en el Journal of Endodontics (38%). Se observó una correlación positiva muy fuerte entre el número de citas en las bases de datos. Los 100 artículos más citados fueron publicados principalmente por revistas europeas o estadounidenses, con diseños de laboratorio e intervenciones multifacéticas. El presente estudio conmemoró el centenario del HC, destacando el papel y la importancia de este biomaterial dental. Celebrando o centenário do hidróxido de cálcio (HC), o objetivo desse estudo foi analisar os 100 artigos mais citados sobre esse biomaterial. A análise bibliométrica foi realizada na base de dados Web of Science Core Collection (WoS-CC). Título, informações sobre autoria, desenho do estudo, ano, periódico, número de citações, uso do HC e áreas da Odontologia foram extraídos. O número de citações nas bases de dados WoS-CC, Scopus e Google Scholar foi cruzado com a correlação de Spearman. Dos 1.596 artigos identificados, foi compilada uma lista com os 100 artigos mais citados. O número de citações no WoS-CC variou de 78 a 384 (média: 131,4). Os principais usos do HC foram: medicação intracanal (61%) e proteção pulpar (29%). As áreas da Odontologia com mais estudos sobre HC foram Endodontia (62%) e Dentística (30%). O desenho de estudo mais frequente foi laboratorial (44%). Trezentos e trinta e cinco autores de 29 países foram identificados. Os Estados Unidos da América (EUA) foram o país líder com 23 artigos. Dag Ørstavik foi o autor com mais artigos e citações (9 artigos; 1.118 citações). A maioria dos artigos foi publicada entre 1991 e 2015 e no Journal of Endodontics (38%). Foi observada uma correlação positiva muito forte entre o número de citações nas bases de dados. Os 100 artigos mais citados foram publicados principalmente por periódicos europeus ou dos EUA, com desenhos laboratoriais e de intervenções multifacetadas. O presente estudo comemorou o centenário do HC, destacando o papel e a importância deste biomaterial odontológico.
- Published
- 2022
- Full Text
- View/download PDF
169. New Tissue Engineering Study Findings Recently Were Reported by Researchers at Zhejiang Chinese Medicine University (An Injectable, Self-healing and Degradable Hydrogel Scaffold As a Functional Biocompatible Material for Tissue Engineering...).
- Abstract
Keywords: Hangzhou; People's Republic of China; Asia; Alcohols; Biocompatible Materials; Bioengineering; Biomedical Engineering; Biomedical and Dental Materials; Biomedicine; Biotechnology; Drugs and Therapies; Emerging Technologies; Engineering; Health and Medicine; Hydrogel; Nanoparticles; Nanotechnology; Organic Chemicals; Polyethylene Glycols; Risk and Prevention; Tissue Engineering EN Hangzhou People's Republic of China Asia Alcohols Biocompatible Materials Bioengineering Biomedical Engineering Biomedical and Dental Materials Biomedicine Biotechnology Drugs and Therapies Emerging Technologies Engineering Health and Medicine Hydrogel Nanoparticles Nanotechnology Organic Chemicals Polyethylene Glycols Risk and Prevention Tissue Engineering 238 238 1 05/22/23 20230525 NES 230525 2023 MAY 25 (NewsRx) -- By a News Reporter-Staff News Editor at Blood Weekly -- A new study on Biomedical Engineering - Tissue Engineering is now available. According to the news editors, the research concluded: "In addition, given their no cytotoxicity and mild inflammation in vivo, the hydrogel scaffolds will be important for tissue engineering and drug delivery applications.". [Extracted from the article]
- Published
- 2023
170. Study Findings from Shenzhen University Broaden Understanding of Biosensors (Biocompatible Material-based Flexible Biosensors: From Materials Design To Wearable/implantable Devices and Integrated Sensing Systems).
- Published
- 2023
171. Patent Application Titled "Connection System For Transmitting Energy And/Or Data From And/Or To An Implantable Blood Pump, And Ventricular Assist Device" Published Online (USPTO 20230104918).
- Abstract
"The proposed connection system for transmitting energy and/or data from and/or to an implantable blood pump comprises a first connection unit, which can be connected or is connected to the blood pump, "and a second connection unit, which can be connected or is connected to a control and/or energy unit. The connection system according to claim 4, wherein the mechanical connection means establishes a connection between the first connection unit and the second connection unit requiring an action of force of at least 10 N in order to be released. The connection system according to claim 1, further comprising: a mechanical connection means by which the first connection unit and the second connection unit can be releasably connected to each other. [Extracted from the article]
- Published
- 2023
172. Patent Issued for Electrically anesthetizing a peripheral nerve with on-demand electrical nerve block for chronic pain management (USPTO 11617884).
- Subjects
HYPNOTISM ,NERVE block ,PAIN management ,PERIPHERAL nervous system ,CHRONIC pain ,PATENT offices ,INVENTORS - Abstract
These treatment modalities are ill suited to address the needs of patients in terms of adequate pain relief, quality of life, and convenience, making patients feel as if their pain management is out of their control." OD-ENB is a patient-specific intervention that can be adjusted over time to provide sustained relief for a long period of time and is customizable for the individual patient, giving patients control of their pain management without opioids. The neuromodulation device of claim 1, wherein the DC is delivered to the neural tissue as an ionic current, wherein a blocking electrode converts the DC to the ionic current delivered by the blocking electrode contact. [Extracted from the article]
- Published
- 2023
173. Patent Issued for Plating depth gauge and countersink instrument (USPTO 11596419).
- Abstract
The kit of claim 1, wherein the shaft comprises a biocompatible material selected from the group consisting of stainless steel, aluminum, titanium alloy, cobalt alloy, titanium ceramic, aluminum oxide, zirconia, silicone, and plastic. Keywords: Aluminum; Biocompatible Materials; Bioengineering; Biomedical and Dental Materials; Biomedicine; Biotechnology; Bone Research; Business; Flower Orthopedics Corporation; Health and Medicine; Light Metals; Risk and Prevention; Titanium EN Aluminum Biocompatible Materials Bioengineering Biomedical and Dental Materials Biomedicine Biotechnology Bone Research Business Flower Orthopedics Corporation Health and Medicine Light Metals Risk and Prevention Titanium 9315 9315 1 03/27/23 20230402 NES 230402 2023 MAR 31 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- A patent by the inventors Burckhardt, Oliver (Philadelphia, PA, US), Garvey, Brian (Media, PA, US), Levin, John (West Palm Beach, FL, US), Rzasa, Kevin (Upper Chichester, PA, US), filed on April 20, 2020, was published online on March 7, 2023, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. The following quote was obtained by the news editors from the background information supplied by the inventors: "During certain orthopedic procedures, it is necessary to use a countersink to prepare the bone for the seating of a screw. [Extracted from the article]
- Published
- 2023
174. Patent Issued for Biological tissue rootage face, implant, method for forming biological tissue rootage face, and method for producing implant (USPTO 11596505).
- Abstract
Co. Ltd EN Biocompatible Materials Bioengineering Biomedical and Dental Materials Biomedicine Biotechnology Bone Research Business Dentistry Health and Medicine Nantoh. When adhesion of the dental implant with a gingiva is insufficient, the gingiva has inflammation, and the gingiva (gum) may be contracted, or an alveolar bone may be reduced (bone resorption). [Extracted from the article]
- Published
- 2023
175. Patent Issued for Systems and methods for surgical implant guidance and positioning with optical surface imaging (USPTO 11589997).
- Abstract
The method as recited in claim 1, wherein the image of the patient is acquired when the optical tracker is mechanically coupled to the surgical implant or surgical tool, and wherein the image of the patient visually depicts a mechanical relationship between the optical tracker and the surgical implant or surgical tool. Keywords: Arthroplasty; Biocompatible Materials; Bioengineering; Biomedical and Dental Materials; Biomedicine; Biotechnology; Bone Research; Health and Medicine; Orthopedic Procedures; Sunnybrook Research Institute; Surgery EN Arthroplasty Biocompatible Materials Bioengineering Biomedical and Dental Materials Biomedicine Biotechnology Bone Research Health and Medicine Orthopedic Procedures Sunnybrook Research Institute Surgery 9621 9621 1 03/23/23 20230324 NES 230324 2023 MAR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- A patent by the inventors Burns, David M. (Toronto, CA), Robert, Normand (Toronto, CA), Whyne, Cari M. (Toronto, CA), filed on September 6, 2019, was published online on February 28, 2023, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. The following quote was obtained by the news editors from the background information supplied by the inventors: "Glenoid component position is an important factor for post-operative function and long-term implant survival in both anatomic and reverse total shoulder arthroplasty. [Extracted from the article]
- Published
- 2023
176. "Bioartificial Pancreas" in Patent Application Approval Process (USPTO 20230053679).
- Abstract
"Description of the Related Art "Type 1 diabetes is a chronic metabolic disorder characterized by the body's inability to produce adequate amounts of insulin for regulating blood sugar. A tubular wall of the bio-absorbable stent may include one or more blood flow pathways for oxygenating the blood vessel and promoting neovascularization of the pancreatic islet cells. Keywords: Artificial Organs; Artificial Pancreas; Bioartificial Pancreas; Biocompatible Materials; Bioengineering; Biomedical Engineering; Biomedical and Dental Materials; Biomedicine; Biotechnology; Drugs and Therapies; Endocrinology; Gastroenterology; Glucagon; Health and Medicine; Hormones; Insulin Dependent Diabetes Mellitus; Metabolic Disorders; Nutritional and Metabolic Diseases and Conditions; Pancreas; Pancreas Research; Patent Application; Peptide Hormones; Peptide Proteins; Proinsulin; Type 1 Diabetes EN Artificial Organs Artificial Pancreas Bioartificial Pancreas Biocompatible Materials Bioengineering Biomedical Engineering Biomedical and Dental Materials Biomedicine Biotechnology Drugs and Therapies Endocrinology Gastroenterology Glucagon Health and Medicine Hormones Insulin Dependent Diabetes Mellitus Metabolic Disorders Nutritional and Metabolic Diseases and Conditions Pancreas Pancreas Research Patent Application Peptide Hormones Peptide Proteins Proinsulin Type 1 Diabetes 556 556 1 03/23/23 20230317 NES 230317 2023 MAR 16 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- A patent application by the inventors Kramer, Thomas A. (San Carlos, CA, US); Photiadis, Douglas Marc (Alexandria, VA, US); Photiadis, Sara Joan (San Francisco, CA, US), filed on November 4, 2022, was made available online on February 23, 2023, according to news reporting originating from Washington, D.C., by NewsRx correspondents. [Extracted from the article]
- Published
- 2023
177. Patent Application Titled "Biocompatible Electromechanical Connection For Ceramic Substrate Electronics For Biomedical Implant" Published Online (USPTO 20230049960).
- Abstract
The antenna may connect to the electronics of the implantable device using vias to form the electrical connection with the associated electronics. The biocompatible device of claim 11, wherein the ferrule comprises one of a platinum-iridium (Pt-Ir) material or an implant grade stainless steel.". [Extracted from the article]
- Published
- 2023
178. Synthesis, characterization, and incorporation of upconverting nanoparticles into a dental adhesive
- Author
-
Lesseux, Guilherme Gorgen, 1989, Lancellotti, Ailla Carla Rocha Acosta, 1982, Martínez, Eduardo David, Urbano, Ricardo Rodrigues, 1974, Giannini, Marcelo, 1969, and UNIVERSIDADE ESTADUAL DE CAMPINAS
- Subjects
Materiais biomédicos ,Nanotecnologia ,Adhesives ,Biomedical and dental materials ,Adesivos ,Nanotechnology ,Artigo original ,Análise espectral ,Biomedical materials ,Spectrum analysis - Abstract
Agradecimentos: This study was supported by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil (Capes – Finance Code 001 and grants #A043-2013 and #1777/2014), by grants # 2011/19924-2, 2012/04870-7 and 2012/05903 of the São Paulo Research Foundation (Fapesp) and by grant #OAICE047-2017 of the University of Costa Rica Abstract: The purpose of this study was to describe the synthesis, characterization, and functionalization of b-NaYF4:30%Yb/0.5%Tm upconverting nanocrystals for use as nanofillers in a dental adhesive and microscopically evaluate the interface between the particles and a commercial adhesive. The upconverting nanoparticles were synthesized and purified by thermal decomposition, and their chemical composition determined by energy dispersive X-Ray spectroscopy. The crystalline structure was characterized using X-Ray diffraction and morphology and size were observed with scanning and transmission electron microscopy. Upconverting emission was evaluated by spectrophotometry irradiating the particles with a 975 nm diode laser. Particles were functionalized with polyacrylic acid and the success was confirmed by measurement of Zeta Potential and transmission electron microscopy. The results of X-ray diffraction found a pure hexagonal phase crystalline pattern. Scanning electron microscopy showed uniform dispersion of hexagonal-shaped particles of approximately 150 nm. Upconversion emission was observed in 344 nm, 361 nm, 450 nm, 474nm, 646 nm, 803 nm. Functionalization success was confirmed by formation of a stable aqueous colloid with a Zeta potential of -29.5mV and the absence of voids in the particle-adhesive interface on the transmission electron microscopy images. The reported synthesis and functionalization process produced upconverting nanoparticles emitting photons within the blue spectral region (450 nm and 474 nm) COORDENAÇÃO DE APERFEIÇOAMENTO DE PESSOAL DE NÍVEL SUPERIOR - CAPES FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESP Aberto
- Published
- 2021
179. Synthesis, characterization, and incorporation of upconverting nanoparticles into a dental adhesive
- Author
-
Rafael Rocha Pacheco, Ali Francisco Garcia-Flores, Jorge Rodrigo Soto-Montero, Guilherme Gorgen Lesseux, Ailla Carla Rocha Acosta Lancelotti, Eduardo David Martinez, Carlos Rettori, Ricardo Rodrigues Urbano, Frederick Allen Rueggeberg, and Marcelo Giannini
- Subjects
Microscopy, Electron, Transmission ,X-Ray Diffraction ,Dentistry ,Adhesives ,Spectrum Analysis ,Nanotechnology ,Dental Cements ,Nanoparticles ,RK1-715 ,General Materials Science ,Biomedical and Dental Materials - Abstract
The purpose of this study was to describe the synthesis, characterization, and functionalization of b-NaYF4:30%Yb/0.5%Tm upconverting nanocrystals for use as nanofillers in a dental adhesive and microscopically evaluate the interface between the particles and a commercial adhesive. The upconverting nanoparticles were synthesized and purified by thermal decomposition, and their chemical composition determined by energy dispersive X-Ray spectroscopy. The crystalline structure was characterized using X-Ray diffraction and morphology and size were observed with scanning and transmission electron microscopy. Upconverting emission was evaluated by spectrophotometry irradiating the particles with a 975 nm diode laser. Particles were functionalized with polyacrylic acid and the success was confirmed by measurement of Zeta Potential and transmission electron microscopy. The results of X-ray diffraction found a pure hexagonal phase crystalline pattern. Scanning electron microscopy showed uniform dispersion of hexagonal-shaped particles of approximately 150 nm. Upconversion emission was observed in 344 nm, 361 nm, 450 nm, 474nm, 646 nm, 803 nm. Functionalization success was confirmed by formation of a stable aqueous colloid with a Zeta potential of −29.5mV and the absence of voids in the particle-adhesive interface on the transmission electron microscopy images. The reported synthesis and functionalization process produced upconverting nanoparticles emitting photons within the blue spectral region (450 nm and 474 nm).
- Published
- 2021
- Full Text
- View/download PDF
180. Tara Gum as a Controlled Delivery System of Fluoride in Toothpaste: In Vitro Enamel Remineralization Study
- Author
-
Vanessa Feitosa Alves, Fábio Correia Sampaio, Nayanna Lana Soares Fernandes, Andressa Feitosa Bezerra de Oliveira, and Ingrid Andrade Meira
- Subjects
Remineralisation ,Toothpaste ,business.product_category ,Enamel paint ,Chemistry ,Polymers ,Positive control ,RK1-715 ,Demineralization ,chemistry.chemical_compound ,Animal science ,visual_art ,Controlled delivery ,Dentistry ,Pediatrics, Perinatology and Child Health ,visual_art.visual_art_medium ,Dentifrice ,business ,Fluoride ,General Dentistry ,Dentifrices ,Toothpastes ,Biomedical and Dental Materials - Abstract
Objective: To evaluate the remineralizing potential of a hydrocolloid-based, controlled fluoride-releasing system added to dentifrice formulas. Material and Methods: Sixty-five human enamel blocks were prepared and the surface microhardness (SH0) values were determined. The artificial caries lesions were induced and the demineralization surface microhardness (SH1) was evaluated. The blocks were randomly allocated into five groups (n = 13): (1) 100-TGF (100% NaF with Tara gum added); (2) 50-TGF (50% free NaF + 50% NaF with Tara gum added); (3) 100% TG (100% Tara gum without fluoride); (4) 100% NaF (positive control); and (5) placebo (without Tara gum and NaF). The blocks were submitted to 7 days pH cycling and treated with dentifrice slurries twice a day. Finally, surface hardness (SH2) was assessed and the percentage of surface hardness recovery (%SMHR) was calculated. Analysis of variance (ANOVA) followed by Bonferroni test was used for statistical analysis . Results: A positive %SMHR was found in the 100% NaF (5.07) and 50-TGF (0.64) groups, while the 100-TGF (-1.38), 100% TG (-3.88) and placebo (-0.52) did not undergo remineralization. Statistically significant differences were observed between 100% NaF and all the groups except for 50-TGF (p
- Published
- 2020
181. The Role of Epigenetic Functionalization of Implants and Biomaterials in Osseointegration and Bone Regeneration—A Review †
- Author
-
Lena Larsson, Christer Dahlin, Farah Asa'ad, Goda Pelanyte, and Jincy Philip
- Subjects
Implant surface ,Bone Regeneration ,Cost effectiveness ,Pharmaceutical Science ,Context (language use) ,Biocompatible Materials ,02 engineering and technology ,Review ,Bioinformatics ,Osseointegration ,Analytical Chemistry ,Epigenesis, Genetic ,lcsh:QD241-441 ,03 medical and health sciences ,lcsh:Organic chemistry ,dental implants ,Drug Discovery ,Medicine ,biomedical and dental materials ,Animals ,Humans ,Epigenetics ,Physical and Theoretical Chemistry ,Bone regeneration ,030304 developmental biology ,Epigenomics ,0303 health sciences ,business.industry ,Regeneration (biology) ,Organic Chemistry ,021001 nanoscience & nanotechnology ,microRNAs ,Chemistry (miscellaneous) ,epigenomics ,Molecular Medicine ,0210 nano-technology ,business - Abstract
The contribution of epigenetic mechanisms as a potential treatment model has been observed in cancer and autoimmune/inflammatory diseases. This review aims to put forward the epigenetic mechanisms as a promising strategy in implant surface functionalization and modification of biomaterials, to promote better osseointegration and bone regeneration, and could be applicable for alveolar bone regeneration and osseointegration in the future. Materials and Methods: Electronic and manual searches of the literature in PubMed, MEDLINE, and EMBASE were conducted, using a specific search strategy limited to publications in the last 5 years to identify preclinical studies in order to address the following focused questions: (i) Which, if any, are the epigenetic mechanisms used to functionalize implant surfaces to achieve better osseointegration? (ii) Which, if any, are the epigenetic mechanisms used to functionalize biomaterials to achieve better bone regeneration? Results: Findings from several studies have emphasized the role of miRNAs in functionalizing implants surfaces and biomaterials to promote osseointegration and bone regeneration, respectively. However, there are scarce data on the role of DNA methylation and histone modifications for these specific applications, despite being commonly applied in cancer research. Conclusions: Studies over the past few years have demonstrated that biomaterials are immunomodulatory rather than inert materials. In this context, epigenetics can act as next generation of advanced treatment tools for future regenerative techniques. Yet, there is a need to evaluate the efficacy/cost effectiveness of these techniques in comparison to current standards of care.
- Published
- 2020
182. Challenges in creating dissectible anatomical 3D prints for surgical teaching
- Author
-
Quentin A. Fogg, Michelle D. Lazarus, Paul G. McMenamin, John Crock, Ratheesraj Ratinam, and Michelle R. Quayle
- Subjects
Models, Anatomic ,0301 basic medicine ,3d printed ,Histology ,Teaching Materials ,Computer science ,education ,Anatomical structures ,ComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISION ,3D printing ,Review Article ,Tissue handling ,Specialties, Surgical ,Biomechanical Phenomena ,03 medical and health sciences ,0302 clinical medicine ,Human–computer interaction ,Humans ,Simulation Training ,Molecular Biology ,Ecology, Evolution, Behavior and Systematics ,Biomedical and Dental Materials ,ComputingMethodologies_COMPUTERGRAPHICS ,Haptic technology ,Education, Medical ,business.industry ,Cell Biology ,Surgical training ,030104 developmental biology ,Printing, Three-Dimensional ,Surgical Models ,Anatomy ,business ,030217 neurology & neurosurgery ,Developmental Biology - Abstract
Three-dimensional (3D) printing, or additive manufacturing, is now a widely used tool in pre-operative planning, surgical teaching and simulator training. However, 3D printing technology that produces models with accurate haptic feedback, biomechanics and visuals for the training surgeon is not currently available. Challenges and opportunities in creating such surgical models will be discussed in this review paper. Surgery requires proper tissue handling as well as knowledge of relevant anatomy. To prepare doctors properly, training models need to take into account the biomechanical properties of the anatomical structures that will be manipulated in any given operation. This review summarises and evaluates the current biomechanical literature as it relates to human tissues and correlates the impact of this knowledge on developing high fidelity 3D printed surgical training models. We conclude that, currently, a printer technology has not yet been developed which can replicate many of the critical qualities of human tissue. Advances in 3D printing technology will be required to allow the printing of multi-material products to achieve the mechanical properties required.
- Published
- 2019
- Full Text
- View/download PDF
183. Advanced electronic skin devices for healthcare applications
- Author
-
Wen Cheng, Huiting Wang, Yun Li, Yi Shi, Zhong Ma, Sheng Li, and Lijia Pan
- Subjects
Computer science ,Biomedical Engineering ,Electronic skin ,3D printing ,Wearable computer ,Biocompatible Materials ,02 engineering and technology ,Biosensing Techniques ,010402 general chemistry ,Administration, Cutaneous ,01 natural sciences ,Human health ,Wearable Electronic Devices ,Human–computer interaction ,Humans ,General Materials Science ,Inkjet printing ,Biomedical and Dental Materials ,Monitoring, Physiologic ,integumentary system ,business.industry ,General Chemistry ,General Medicine ,021001 nanoscience & nanotechnology ,Biocompatible material ,0104 chemical sciences ,0210 nano-technology ,Tissue pressure ,Wearable Electronic Device ,business - Abstract
Electronic skin, a kind of flexible electronic device and system inspired by human skin, has emerged as a promising candidate for wearable personal healthcare applications. Wearable electronic devices with skin-like properties will provide platforms for continuous and real-time monitoring of human physiological signals such as tissue pressure, body motion, temperature, metabolites, electrolyte balance, and disease-related biomarkers. Transdermal drug delivery devices can also be integrated into electronic skin to enhance its non-invasive, real-time dynamic therapy functions. This review summarizes the recent progress in electronic skin devices for applications in human health monitoring and therapy systems as well as several potential mass production technologies such as inkjet printing and 3D printing. The opportunities and challenges in broadening the applications of electronic skin devices in practical healthcare are also discussed.
- Published
- 2020
184. Hematite Nanoparticles from Unexpected Reaction of Ferrihydrite with Concentrated Acids for Biomedical Applications
- Author
-
Maxim P. Nikitin, Maria N. Yakovtseva, E.N. Mochalova, Eugene L. Kolychev, A.V. Lunin, A. A. Lizunova, and V. R. Cherkasov
- Subjects
Materials science ,Iron oxide ,Pharmaceutical Science ,Nanoparticle ,Infrared spectroscopy ,bioconjugation ,02 engineering and technology ,Ferric Compounds ,ferrihydrite ,Article ,Analytical Chemistry ,lcsh:QD241-441 ,03 medical and health sciences ,Ferrihydrite ,chemistry.chemical_compound ,lcsh:Organic chemistry ,hematite nanoparticles ,Drug Discovery ,Humans ,nanoparticle synthesis ,antibodies ,Physical and Theoretical Chemistry ,Fourier transform infrared spectroscopy ,bioimaging ,030304 developmental biology ,Biomedical and Dental Materials ,0303 health sciences ,Spectrum Analysis ,Organic Chemistry ,polymer coating ,Hematite ,021001 nanoscience & nanotechnology ,HER2/neu ,cancer cell targeting ,chemistry ,Chemical engineering ,Chemistry (miscellaneous) ,visual_art ,visual_art.visual_art_medium ,Molecular Medicine ,Magnetic Iron Oxide Nanoparticles ,Selected area diffraction ,0210 nano-technology ,Acids ,Iron oxide nanoparticles ,red blood cells - Abstract
The development of synthetic ways to fabricate nanosized materials with a well-defined shape, narrow-sized distribution, and high stability is of great importance to a rapidly developing area of nanotechnology. Here, we report an unusual reaction between amorphous two-line ferrihydrite and concentrated sulfuric or other mineral and organic acids. Instead of the expected dissolution, we observed the formation of new narrow-distributed brick-red nanoparticles (NPs) of hematite. Different acids produce similar nanoparticles according to scanning (SEM) and transmission electron microscopy (TEM), selected area electron diffraction (SAED), X-ray diffraction (XRD), infrared spectroscopy (FTIR), and energy-dispersive X-ray spectroscopy (EDX). The reaction demonstrates new possibilities for the synthesis of acid-resistant iron oxide nanoparticles and shows a novel pathway for the reaction of iron hydroxide with concentrated acids. The biomedical potential of the fabricated nanoparticles is demonstrated by the functionalization of the particles with polymers, fluorescent labels, and antibodies. Three different applications are demonstrated: i) specific targeting of the red blood cells, e.g., for red blood cell (RBC)-hitchhiking, ii) cancer cell targeting in vitro, iii) infrared ex vivo bioimaging. This novel synthesis route may be useful for the development of iron oxide materials for such specificity-demanding applications such as nanosensors, imaging, and therapy.
- Published
- 2020
185. RoBDEMAT: A risk of bias tool and guideline to support reporting of pre-clinical dental materials research and assessment of systematic reviews.
- Author
-
Delgado AH, Sauro S, Lima AF, Loguercio AD, Della Bona A, Mazzoni A, Collares FM, Staxrud F, Ferracane J, Tsoi J, Amato J, Neuhaus KW, Ceballos L, Breschi L, Hannig M, Melo MA, Özcan M, Scotti N, Opdam N, Yamaguchi S, Paris S, Turkun LS, Doméjean S, Rosa V, Palin W, and Schwendicke F
- Subjects
- Systematic Reviews as Topic, Bias, Dental Materials, Publications, Checklist
- Abstract
Objectives: To develop a risk of bias tool for pre-clinical dental materials research studies that aims to support reporting of future investigations and improve assessment in systematic reviews., Methods: A four-stage process following EQUATOR network recommendations was followed, which included project launch, literature review, Delphi process and the tool finalization. With the support of the European Federation of Conservative Dentistry (EFCD) and the Dental Materials Group of the International Association for Dental Research (DMG-IADR), a total of 26 expert stakeholders were included in the development and Delphi vote of the initial proposal. The proposal was built using data gathered from the literature review stage. During this stage, recent systematic reviews featuring dental materials research, and risk of bias tools found in the literature were comprehensively scanned for bias sources. The experts thus reached a consensus for the items, domains and judgement related to the tool, allowing a detailed guide for each item and corresponding signalling questions., Results: The tool features nine items in total, spread between 4 domains, pertaining to the following types of bias: bias related to planning and allocation (D1), specimen preparation (D2), outcome assessment (D3) and data treatment and outcome reporting (D4). RoBDEMAT, as presented, features signalling questions and a guide that can be used for RoB judgement. Its use as a checklist is preferred over a final summary score., Conclusion: RoBDEMAT is the first risk of bias tool for pre-clinical dental materials research, supported and developed by a broad group of expert stakeholders in the field, validating its future use., Clinical Significance: This new tool will contribute the study field by improving the scientific quality and rigour of dental materials research studies and their systematic reviews. Such studies are the foundation and support of future clinical research and evidence-based decisions., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
186. "Magnetoelastic Microcarriers And Monitoring System" in Patent Application Approval Process (USPTO 20230031122).
- Subjects
PATENT applications ,DENTAL materials ,BIOMEDICAL materials - Published
- 2023
187. Investigators at Changhai Hospital Discuss Findings in Tissue Engineering (In Vitro and In Vivo Investigation of Chrysin Chelated Copper Complex As Biocompatible Materials for Bone Tissue Engineering Applications).
- Abstract
Shanghai, People's Republic of China, Asia, Biocompatible Materials, Bioengineering, Biomedical Engineering, Biomedicine, Biotechnology, Bone Regeneration, Bone Substitutes, Bone-Tissue Engineering, Engineering, Health and Medicine, Tissue Engineering, Biomedical and Dental Materials Keywords: Shanghai; People's Republic of China; Asia; Biocompatible Materials; Bioengineering; Biomedical Engineering; Biomedical and Dental Materials; Biomedicine; Biotechnology; Bone Regeneration; Bone Substitutes; Bone-Tissue Engineering; Engineering; Health and Medicine; Tissue Engineering EN Shanghai People's Republic of China Asia Biocompatible Materials Bioengineering Biomedical Engineering Biomedical and Dental Materials Biomedicine Biotechnology Bone Regeneration Bone Substitutes Bone-Tissue Engineering Engineering Health and Medicine Tissue Engineering 2023 FEB 23 (NewsRx) -- By a News Reporter-Staff News Editor at Blood Weekly -- A new study on Biomedical Engineering - Tissue Engineering is now available. [Extracted from the article]
- Published
- 2023
188. Patent Issued for Dental implants with markers for determining three-dimensional positioning (USPTO 11559379).
- Abstract
The method as recited in claim 1, wherein the scanning apparatus comprises at least one of a computed tomography (CT) scan machine, x-ray machine, or magnetic resonance imaging (MRI) machine. For example, at present, a patient typically is required to visit the practitioner multiple times as various iterations of the prosthetic are developed and fitted to the implant installed in the patient's jaw, and to interface the prosthetic with the surrounding hard and soft tissues of the patient. Such imaging techniques may include, but are not particularly limited to CT imaging, MRI imaging, x-ray imaging, and ultrasound. [Extracted from the article]
- Published
- 2023
189. Patent Issued for GPNMB compositions for treatment of skin wounds (USPTO 11554158).
- Published
- 2023
190. Patent Issued for Oral patient tracking device and method of using the same (USPTO 11547491).
- Abstract
The patient tracking device as recited in claim 4 wherein the electromagnetic sensor is disposed within a sensor cavity disposed between the first surface and the second surface and a biocompatible material is disposed within the sensor cavity to retain the sensor. The patient tracking device as recited in claim 11 wherein the sensor housing defines a cavity and the electromagnetic sensor is disposed within the cavity within the sensor housing in between the first and second surfaces, wherein a biocompatible material is injected into an unfilled portion of the cavity to secure the sensor in the sensor housing. "In one aspect of the disclosure, a patient tracking device for insertion into a body cavity includes a flexible conformable sensor housing having a sensor cavity therein. [Extracted from the article]
- Published
- 2023
191. Evaluation of the friction force generated by monocristalyne and policristalyne ceramic brackets in sliding mechanics.
- Author
-
Pimentel, Roberta Ferreira, Fortes de Oliveira, Roberto Sotto Maior, Miranda Chaves, Maria das Graças Afonso, Elias, Carlos Nelson, and Gravina, Marco Abdo
- Subjects
ORTHODONTIC appliances ,SALIVA ,DENTAL ceramics ,DENTAL materials ,ORTHODONTICS - Abstract
Copyright of Dental Press Journal of Orthodontics is the property of Dental Press International and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2013
- Full Text
- View/download PDF
192. In vitro evaluation of force degradation of elastomeric chains used in Orthodontics.
- Author
-
Weissheimer, André, Locks, Arno, de Menezes, Luciane Macedo, Borgatto, Adriano Ferreti, and Derech, Carla D'Agostini
- Subjects
ORTHODONTIC appliances ,ELASTOMERS in dentistry ,DENTAL bonding ,DENTAL materials ,ORTHODONTICS - Abstract
Copyright of Dental Press Journal of Orthodontics is the property of Dental Press International and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2013
- Full Text
- View/download PDF
193. Irregular Implant Design Decreases Periimplant Stress and Strain Under Oblique Loading
- Author
-
Xiucheng Li, Jiwu Zhang, Ling He, Songhe Lu, Hongcheng Hu, and Zhihui Tang
- Subjects
Dental Stress Analysis ,Materials science ,0206 medical engineering ,Abutment ,02 engineering and technology ,Models, Biological ,Stress (mechanics) ,03 medical and health sciences ,0302 clinical medicine ,Alveolar Process ,Humans ,Principal stress ,Biomedical and Dental Materials ,Dental Implants ,Orthodontics ,Dental Implantation, Endosseous ,Implant design ,Stress–strain curve ,Oblique case ,030206 dentistry ,020601 biomedical engineering ,Dental Prosthesis Design ,Stress, Mechanical ,Implant ,Oral Surgery - Abstract
Objectives To investigate whether a different implant geometry with the same potential contact surface area (PCSA) affects the principal stress and strains in bone. Material and methods Three-dimensional finite-element models were created with a single endosseous implant embedded in bone. The irregular (IR) dental root-analog implant and regular (R) cylindrical implant with the same PCSA 350 mm were modeled, keeping the size of the thinnest implant wall 0.8 mm, and the thinnest bone wall 1 mm. The regular or irregular abutments were either 4.5 mm lower than the platform of the implants or 5 mm higher than the platform of the implants, both with the taper 1.44°. A 100 N vertical or 100 N vertical/50 N horizontal occlusal loading was applied. The biomechanical behaviors of periimplant bone were recorded. Results The IR implant design experienced lower periimplant stress and strain under oblique loading than that of R implant design. In the IR implant design, comparable stress in bone, implant, and abutment were found under 100 N vertical loading or 100 N vertical/50 N horizontal loading. In the R implant design, much higher stress in bone, implant, and abutment were found under 100 N vertical/50 N horizontal loading than that under 100 N vertical loading. Conclusion Irregular dental root-analog implant is a biomechanically favorable design principle for decreasing periimplant stress and strain under oblique loading.
- Published
- 2017
- Full Text
- View/download PDF
194. Effect of Listerine Mouthwash with Green Tea on the Inhibition of Streptococcus Mutans: A Microbiologic Study
- Author
-
Niloofar Moein, Ashkan Salari, Amir Tajer, Fereshteh Naser Alavi, and Ali Mojtahedi
- Subjects
Microbiological Techniques ,food.ingredient ,biology ,Post hoc ,Chlorhexidine ,Mouthwashes ,biology.organism_classification ,Green tea ,Streptococcus mutans ,chemistry.chemical_compound ,food ,stomatognathic system ,chemistry ,Statistical significance ,Antimicrobial effect ,Pediatrics, Perinatology and Child Health ,medicine ,Agar ,Food science ,Growth inhibition ,General Dentistry ,Biomedical and Dental Materials ,medicine.drug - Abstract
Objective: To evaluate in vitro the antimicrobial effect of Listerine-green tea mouthwash on Streptococcus mutans (SM) in comparison with 0.12% Chlorhexidine (CHX) and Listerine-Zero. Material and Methods: The sensitivity and growth inhibition of SM bacterial species were evaluated and compared between Listerine-green tea, 0.12% CHX and Listerine-Zero mouthwashes. Sixty plates containing SM colonies were prepared in three groups (n=20), and growth inhibition zones were measured using the disk diffusion agar test in mm. Data were analyzed with SPSS 21. One-way ANOVA was used to compare the efficacy of the three mouthwashes tested. Post hoc Tukey tests were used for two-by-two comparisons. Statistical significance was defined at P
- Published
- 2020
- Full Text
- View/download PDF
195. Effect of histatin- and statherin-derived engineered salivary peptides on Streptococcus mutans adhesion and on enamel demineralization provoked by cariogenic biofilms
- Author
-
Marin, Lina Maria
- Subjects
Streptococcus mutans ,proteomics ,stomatognathic system ,acquired enamel pellicle ,dental biofilm ,dental caries ,salivary proteins ,Biomedical and Dental Materials - Abstract
Dental biofilm is formed onto dental surfaces covered by a layer of specific salivary proteins and peptides named acquired enamel pellicle (AEP). It was previously demonstrated that the statherin- and histatin-derived engineered salivary peptides DR9-DR9 and DR9-RR14 were able to reduce enamel demineralization and displayed antimicrobial activity against Streptococcus mutans, respectively. However, these studies were carried under experimental conditions that did not mimic caries development induced by biofilm and sucrose exposure, the most cariogenic dietary sugar. In this thesis we assessed the effect of the engineered salivary peptides on 1) the adherence of S. mutans to hydroxyapatite (HAp), and 2) the reduction of enamel demineralization, using a validated S. mutans cariogenic biofilm model. We hypothesized that DR9-DR9 and DR9-RR14 would reduce S. mutans adherence and the cariogenicity of the biofilms, protecting enamel against demineralization. To test this hypothesis, we conducted two in vitro studies. In the first study, hydroxyapatite discs were treated with the peptides to induce AEP formation and then inoculated with S. mutans to quantify adhered bacteria, and to evaluate the total bacterial proteomes after adhesion periods of 2 h, 4 h, and 8 h. In the second study, a validated in vitro cariogenic S. mutans biofilm model was used to test the effect of DR9-DR9 and DR9-RR14 on enamel demineralization under two conditions 1) adsorbed onto the enamel surface forming the AEP, and 2) used to treat the biofilms 2x/day. Biofilms were grown for 144 h and the effect of the peptides on enamel demineralization, biomass, and total and extracellular matrix bacterial proteomes were evaluated. Results showed that DR9-DR9 reduced S. mutans adherence to HAp, but DR9-DR9 and DR9-RR14 did not have a significant effect on the development of the cariogenic biofilms formed. The engineered peptides did not modulate the bacterial proteome, neither when adhered to AEP nor when used to treat the biofilms during their formation. However, DR9-DR9 and DR9-RR14 significantly reduced enamel demineralization, suggesting that they control caries development by a physicochemical mechanism. The combinatory effect of reducing bacteria adhesion and limiting the mineral loss from the dental structure under high cariogenic challenge, suggests that the engineered peptides DR9-DR9 and DR9-RR14 represent a new translational approach for the prevention/treatment of dental caries.
- Published
- 2019
196. Influence of activation mode, fatigue, and ceramic interposition on resin cements’ diametral tensile strength
- Author
-
Lourenço Correr-Sobrinho, Hélio Rodrigues Sampaio-Filho, Paula Nunes Guimarães Paes, and Mauro Sayão de Miranda
- Subjects
Ceramics ,Materials science ,RelyX Unicem ,Polyethylene Glycols ,03 medical and health sciences ,0302 clinical medicine ,Polymethacrylic Acids ,Reference Values ,Immediate loading ,Tensile Strength ,Ultimate tensile strength ,Materials Testing ,General Materials Science ,Bisphenol A-Glycidyl Methacrylate ,030212 general & internal medicine ,Ceramic ,Composite material ,Curing (chemistry) ,Light-Curing of Dental Adhesives ,Biomedical and Dental Materials ,Universal testing machine ,Analysis of Variance ,Self-Curing of Dental Resins ,Reproducibility of Results ,030206 dentistry ,Resin Cements ,lcsh:RK1-715 ,visual_art ,lcsh:Dentistry ,visual_art.visual_art_medium ,Dual cure - Abstract
This study evaluated the influence of activation modes, on Diametral Tensile Strength (DTS) of dual cured resin cements subjected to a Mechanical Fatigue test (MF). Four dual-cured resin cements (RelyX UNICEM [U], RelyX ARC [A], ENFORCE [E] and Nexus 2 [N]) were activated by three different curing modes as follows: Self-Curing (SC), Dual Cure activation with photoactivation executed directly (DC) and Dual Cure activation with Photoactivation Through Porcelain (DCTP). After 24 hours, half of the sample was subjected to 30.000 fatigue cycles at 1 Hz frequency and 12 N load. Then, all specimens were subjected to DTS test in Instron Universal Testing Machine and data were analyzed by three-way ANOVA and Tukey’s Test (5%). The results of DTS test means (MPa) and standard deviation, for each cement factor activated by SC, DC and DCTP was respectively: U (28.12 ± 5.29; 37.44 ± 6.49 and 40.10 ± 4.39), A (49.68 ± 8.42; 55.12 ± 5.16 and 63.43 ± 6.92), E (49.12 ± 3.89; 56.42 ± 8.88 and 56.96 ± 6.45) and N (61.89 ± 11.21; 59.26 ± 9.47 and 62.56 ± 10.93). Turkey’s test indicated that DC is related to the highest DTS values; Nexus 2 DTS remained the same independently of activation mode and that the Porcelain disk interposition enhanced DTS only for RelyX ARC the ANOVA statistical test indicated that MF didn’t alter the DTS values for all experimental groups. MF results clinical implication is that all cements tested exhibited, in an immediate loading, good cross linked bonds quality.
- Published
- 2019
197. Latest Advances on Bacterial Cellulose-Based Materials for Wound Healing, Delivery Systems, and Tissue Engineering
- Author
-
Hélder A. Santos, Gabriela Guedes, Carmen S. R. Freire, Tiago Carvalho, and Filipa L. Sousa
- Subjects
0106 biological sciences ,Engineering ,Bone Regeneration ,Polymers ,Nanotechnology ,Biocompatible Materials ,Regenerative Medicine ,01 natural sciences ,Applied Microbiology and Biotechnology ,Regenerative medicine ,Nanocellulose ,chemistry.chemical_compound ,Drug Delivery Systems ,Tissue engineering ,010608 biotechnology ,Biological property ,Animals ,Humans ,Cellulose ,Biomedical and Dental Materials ,Wound Healing ,Bacteria ,Tissue Engineering ,Tissue Scaffolds ,business.industry ,010401 analytical chemistry ,Membranes, Artificial ,General Medicine ,Prostheses and Implants ,Bridged Bicyclo Compounds, Heterocyclic ,3. Good health ,0104 chemical sciences ,Nanostructures ,chemistry ,Bacterial cellulose ,Wound dressing ,Drug delivery ,Molecular Medicine ,business ,Wound healing - Abstract
Bacterial cellulose (BC) is a nanocellulose form produced by some nonpathogenic bacteria. BC presents unique physical, chemical, and biological properties that make it a very versatile material and has found application in several fields, namely in food industry, cosmetics, and biomedicine. This review overviews the latest state-of-the-art usage of BC on three important areas of the biomedical field, namely delivery systems, wound dressing and healing materials, and tissue engineering for regenerative medicine. BC will be reviewed as a promising biopolymer for the design and development of innovative materials for the mentioned applications. Overall, BC is shown to be an effective and versatile carrier for delivery systems, a safe and multicustomizable patch or graft for wound dressing and healing applications, and a material that can be further tuned to better adjust for each tissue engineering application, by using different methods.
- Published
- 2019
198. Recent Progress in Polyhydroxyalkanoates-Based Copolymers for Biomedical Applications
- Author
-
Xian Jun Loh, Zibiao Li, Yun-Long Wu, and Zheng Luo
- Subjects
0106 biological sciences ,Drug Carriers ,Materials science ,Bacteria ,Tissue Engineering ,Polymers ,Production cost ,Polyhydroxyalkanoates ,010401 analytical chemistry ,Nanotechnology ,Biocompatible Materials ,General Medicine ,Biodegradable Plastics ,01 natural sciences ,Applied Microbiology and Biotechnology ,0104 chemical sciences ,Biodegradation, Environmental ,010608 biotechnology ,Copolymer ,Molecular Medicine ,Animals ,Humans ,Biomedical and Dental Materials - Abstract
In recent years, naturally biodegradable polyhydroxyalkanoate (PHA) monopolymers have become focus of public attentions due to their good biocompatibility. However, due to its poor mechanical properties, high production costs, and limited functionality, its applications in materials, energy, and biomedical applications are greatly limited. In recent years, researchers have found that PHA copolymers have better thermal properties, mechanical processability, and physicochemical properties relative to their homopolymers. This review summarizes the synthesis of PHA copolymers by the latest biosynthetic and chemical modification methods. The modified PHA copolymer could greatly reduce the production cost with elevated mechanical or physicochemical properties, which can further meet the practical needs of various fields. This review further summarizes the broad applications of modified PHA copolymers in biomedical applications, which might shred lights on their commercial applications.
- Published
- 2019
199. Application of bioactive glasses in various dental fields.
- Author
-
Jafari N, Habashi MS, Hashemi A, Shirazi R, Tanideh N, and Tamadon A
- Abstract
Bioactive glasses are a group of bioceramic materials that have extensive clinical applications. Their properties such as high biocompatibility, antimicrobial features, and bioactivity in the internal environment of the body have made them useful biomaterials in various fields of medicine and dentistry. There is a great variation in the main composition of these glasses and some of them whose medical usage has been approved by the US Food and Drug Administration (FDA) are called Bioglass. Bioactive glasses have appropriate biocompatibility with the body and they are similar to bone hydroxyapatite in terms of calcium and phosphate contents. Bioactive glasses are applied in different branches of dentistry like periodontics, orthodontics, endodontics, oral and maxillofacial surgery, esthetic and restorative dentistry. Also, some dental and oral care products have bioactive glasses in their compositions. Bioactive glasses have been used as dental implants in the human body in order to repair and replace damaged bones. Other applications of bioactive glasses in dentistry include their usage in periodontal disease, root canal treatments, maxillofacial surgeries, dental restorations, air abrasions, dental adhesives, enamel remineralization, and dentin hypersensitivity. Since the use of bioactive glasses in dentistry is widespread, there is a need to find methods and extensive resources to supply the required bioactive glasses. Various techniques have been identified for the production of bioactive glasses, and marine sponges have recently been considered as a rich source of it. Marine sponges are widely available and many species have been identified around the world, including the Persian Gulf. Marine sponges, as the simplest group of animals, produce different bioactive compounds that are used in a wide range of medical sciences. Numerous studies have shown the anti-tumor, anti-viral, anti-inflammatory, and antibiotic effects of these compounds. Furthermore, some species of marine sponges due to the mineral contents of their structural skeletons, which are made of biosilica, have been used for extracting bioactive glasses., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
200. Process of Manufacturing Nanoparticles (NGR Peptides with a Biodegradable Polymer) by Electrospraying for Developing an Active Targeting Drug Delivery System for Cancer Therapy
- Author
-
Yamasta, Anthony James
- Subjects
- Electrospray, Drug Delivery, Cancer Therapy, Active Targeting, Encapsulated Drug, Biocompatible Polymer, Amino Acids, Peptides, and Proteins, Biochemistry, Biochemistry, Biophysics, and Structural Biology, Biomedical and Dental Materials, Cancer Biology, Chemicals and Drugs, Diseases, Medicinal and Pharmaceutical Chemistry, Medicine and Health Sciences, Nanomedicine, Nanotechnology, Other Chemicals and Drugs, Pharmaceutics and Drug Design, Surgical Procedures, Operative, Therapeutics
- Abstract
Peptides have shown to have vasculature-homing properties with aminopeptidase N (CD13) which are also expressed on tumor vasculature. Two types of peptides, TAMS-1 U3012DA110-1CSPGAKVRCY{Lys(Biotin)} and Biotin{PEG4}-MEWSLEKGYTIK, were individually electrosprayed with a biodegradable polymer, polycaprolactone (PCL). The peptide solution was created by dissolving 2mg of the peptide into 50ml of DMSO. The PCL solution was created by dissolving PCL in a mixture of Acetic Acid (AA), Formic Acid (FA), and Trifluoroethanol (TFE) in a 9:9:1 ratio. The peptide was coaxially electrosprayed in two different trials (one trial for each peptide) with PCL, where PCL is the core and the peptide is the sheath. Electrospraying parameters included applying a voltage of 44kV, humidity between 35-44%, tip to collector distance at 160mm, core flow rate of 0.5 ml/hr, and a sheath flow rate of 0.7 ml/hr. Development of a transverse axial spinneret was created to add another layer to the nanocapsule for a total of three layers. Samples were created using Fluorescein Sodium Salt as the core, PCL as the 1st sheath, and Rhodamine-6G as the 2nd sheath. Electrospraying parameters included applying a voltage of 43kV, humidity between 35-44%, tip to collector distance at 185mm, core flow rate at 0.1ml/hr with a 27 gauge needle and 5mL Becton plastic syringe, sheath flow rate for the 1st sheath at 0.2ml/hr using the sheath of the coaxial spinneret, sheath flow rate for the 2nd sheath at 0.2ml/hr with a 27 gauge needle and a 5mL Becton plastic syringe mounted onto the transverse spinneret. Ultraviolet-visible (UV-VIS) spectrophotometry is used to detect peptides present in the solution before electrospraying and peptide presence in the nanoparticles after electrospraying. The UV-VIS detected the presence of the TAMS-1 peptide in the electrosprayed nanoparticle at a wavelength of 230nm-280nm. Scanning Electron Microscopy (SEM) was completed to see the morphology of the active tumor targeting biodegradable/biocompatible polymer and the nanocapsules manufactured with three layers. Images showed individual nanocapsules sized at 100nm or less. Conglomerates are found to be 1µm or smaller In vivo biodistribution tests were completed using the two sets of samples created from the two different peptides. TAMS-1 U3012DA110-1CSPGAKVRCY{Lys(Biotin)}, showed uptake to tumors when analyzing the in-vivo biodistribution tests. Nanocapsules electrosprayed with PCL and NGR Peptide, Biotin{PEG4}-MEWSLEKGYTIK did not show uptake to the tumors.
- Published
- 2022
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.